118 related articles for article (PubMed ID: 3387739)
1. [Prevention of progression of kidney insufficiency].
Binswanger U
Schweiz Rundsch Med Prax; 1988 May; 77(19):511-3. PubMed ID: 3387739
[No Abstract] [Full Text] [Related]
2. [Renal effects of angiotensin-converting enzyme inhibitors and their therapeutic use in chronic terminal renal failure].
Ritz E; Mann JF; Rambausek M
Z Kardiol; 1988; 77 Suppl 3():57-60. PubMed ID: 2850688
[No Abstract] [Full Text] [Related]
3. Losartan in patients with renal insufficiency.
de Zeeuw D; Gansevoort RT; de Jong PE
Can J Cardiol; 1995 Aug; 11 Suppl F():41F-44F. PubMed ID: 7664217
[TBL] [Abstract][Full Text] [Related]
4. [ACE inhibitors in kidney diseases--only another antihypertensive agent?].
Ritz E; Stein G
Med Klin (Munich); 1994 Sep; 89(9):473-5. PubMed ID: 7968882
[No Abstract] [Full Text] [Related]
5. [Nephroprotection by inhibition of the renin-angiotensin system--wish or reality?].
Barnas U; Mayer G
Wien Klin Wochenschr; 1995; 107(1):10-4. PubMed ID: 7871784
[TBL] [Abstract][Full Text] [Related]
6. [Inhibition of the progression of renal failure in glomerular diseases].
Ritz E; Siebels M; Fliser D
Internist (Berl); 1993 Apr; 34(4):330-9. PubMed ID: 8486477
[No Abstract] [Full Text] [Related]
7. [ACE inhibitors and the kidney].
Hörl WH
Wien Med Wochenschr; 1996; 146(11):231-4; discussion 234-5. PubMed ID: 8928521
[TBL] [Abstract][Full Text] [Related]
8. [Progression of chronic renal insufficiency and its prevention using angiotensin converting enzyme inhibitors and angiotensin antagonists].
Tesar V
Vnitr Lek; 2003 May; 49(5):365-9. PubMed ID: 12908169
[TBL] [Abstract][Full Text] [Related]
9. [Use of angiotensin converting enzyme inhibitors in nephrology].
Stefanović V; Ivić M; Bogićević M
Srp Arh Celok Lek; 1994; 122(7-8):228-30. PubMed ID: 17974394
[TBL] [Abstract][Full Text] [Related]
10. Glomerular hypertension in the progression of chronic renal failure: role of low protein diet and angiotensin converting enzyme inhibitors.
Cappelli P; Del Rosso G; Di Paolo B; Evangelista M; Albertazzi A
Scand J Urol Nephrol Suppl; 1988; 108():25-30. PubMed ID: 3163827
[No Abstract] [Full Text] [Related]
11. Therapeutic advantages of angiotensin converting enzyme inhibitors in chronic renal disease.
Omata K; Kanazawa M; Sato T; Abe F; Saito T; Abe K
Kidney Int Suppl; 1996 Jun; 55():S57-62. PubMed ID: 8743512
[TBL] [Abstract][Full Text] [Related]
12. [Hypertension--special reference to kidney diseases].
Hayashi M
Nihon Jinzo Gakkai Shi; 2002; 44(5):432-8. PubMed ID: 12216475
[No Abstract] [Full Text] [Related]
13. Chronic renal disease: new therapies to delay kidney replacement.
Michael B; Burke JF
Geriatrics; 1994 Aug; 49(8):33-8. PubMed ID: 8039727
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of chronic renal insufficiency].
Saha H; Wirta O
Duodecim; 1995; 111(15):1479-87. PubMed ID: 9244704
[No Abstract] [Full Text] [Related]
15. Prevention of progression in non-diabetic chronic renal failure.
Becker GJ; Whitworth JA; Ihle BU; Shahinfar S; Kincaid-Smith PS
Kidney Int Suppl; 1994 Feb; 45():S167-70. PubMed ID: 8158888
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the effects of ACE inhibitors and calcium channel blockers on the progression of renal failure.
Zucchelli P; Zuccalà A; Gaggi R
Nephrol Dial Transplant; 1995 Oct; 10 Suppl 9():46-51. PubMed ID: 8643208
[No Abstract] [Full Text] [Related]
17. [Progressive renal failure. Why blood pressure must now be monitored].
Tepel M; van der Giet M; Zidek W
MMW Fortschr Med; 2000 Jun; 142(25):42-4. PubMed ID: 10920669
[TBL] [Abstract][Full Text] [Related]
18. ACE-inhibitors and progression of chronic renal insufficiency: a contribution of Italian clinical research.
Andreucci VE; Gallieni M; Brancaccio D
J Nephrol; 1998; 11(3):105-9. PubMed ID: 9650118
[No Abstract] [Full Text] [Related]
19. Podocytes as a target for treatment with ACE inhibitors and/or angiotensin-receptor blockers.
Kriz W
Kidney Int; 2004 Jan; 65(1):333-4. PubMed ID: 14675067
[No Abstract] [Full Text] [Related]
20. [Mechanism of progression of chronic renal failure and new treatment strategies].
Litwin M
Pol Merkur Lekarski; 2000 Apr; 8(46):301-2. PubMed ID: 10897662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
